Home › Crohn's Disease › South Carolina
Crohn's Disease clinical trials in South Carolina
12 studies for Crohn's Disease are looking for participants at sites in South Carolina.
Cities in South Carolina
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Gastroenterology Associates - Patewood /ID# 283870, Greenville
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Oct 5, 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Palmetto Primary Care Physician Division of Gastroenterology, Summerville
RecruitingPhase 4
Ages 18 to 80 · All sexes · Updated Sep 30, 2026 · NCT06581328Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
- Gastroenterology Associates of Orangeburg /ID# 267548, Orangeburg
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT06548542A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease
- Gastroenterology Associates, PA, Greenville
RecruitingPhase 2
Ages 18 to 75 · All sexes · Updated Sep 25, 2026 · NCT06233461A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
- Palmetto Primary and Specialty Care Physicians, Charleston, Summerville
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT07499232Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
- Gastroenterology Associates - Patewood, Greenville
RecruitingPhase 3
Ages 18 to 70 · All sexes · Updated Sep 24, 2026 · NCT06937099An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
- Johns Hopkins University Gastroenterology and Hepatology-Site Number: 8400116, Columbia
- Biocentric Health Research Center-Site Number: 8400089, Columbia
RecruitingPhase 3
Ages 16 to 80 · All sexes · Updated Sep 23, 2026 · NCT07184931A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- Palmetto Gastroenterology Clinical Research, Summerville
RecruitingPhase 2
Ages 18 to 85 · All sexes · Updated Sep 22, 2026 · NCT06226883A Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis or Crohn's Disease
- Medical University of South Carolina, North Charleston
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated Aug 3, 2026 · NCT06100289A Long-Term Extension Study of Vedolizumab in Children and Teenagers With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Medical University of South Carolina, Charleston
RecruitingPhase 3
Ages 2 to 17 · All sexes · Updated Jun 22, 2026 · NCT06405087A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Greenville
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Mar 12, 2026 · NCT07113522VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease
- Medical University of South Carolina (MUSC), Charleston
RecruitingPhase 4
Ages 18 to 80 · All sexes · Updated Jan 15, 2026 · NCT06257706From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.